1,313
Views
42
CrossRef citations to date
0
Altmetric
Research Article

A high density assay format for the detection of novel cytotoxic agents in large chemical libraries

, , , , , & show all
Pages 931-945 | Received 16 Jul 2007, Accepted 15 Oct 2007, Published online: 20 Oct 2008

References

  • SF Sener. (2005). Disease without borders. CA Cancer J Clin 55:7–9.
  • M Untch, BU Sevin, JP Perras, R Angioli, A Untch, RD Hightower, O Koechli, and HE Averette. (1994). Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel–cisplatin in ovarian cancer in vitro with the ATP cell viability assay. Gyn Oncol 53:44–49.
  • T Mosmann. (1983). Rapid colorimetric assay for the cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63.
  • C Korzeniewski, and DM Callewaert. (1983). An enzyme release assay for natural cytotoxicity. J Immunol Meth 64:313–320.
  • MA Baker, GJ Cerniglia, and A Zaman. (1990). Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190:360–365.
  • RD Fields, and MV Lancaster. (1993). Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab 11:48–50.
  • RW Horobin. (2001). The problem of proprietary dyes, with special reference to Alamar blue, a proprietary dye revealed. Biotechnic Histochem 76:163–164.
  • J O'Brien, I Wilson, T Orton, and F Pognan. (2000). Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267:5421–5426.
  • SL Voytik-Harbin, AO Brightman, B Waisner, CH Lamar, and SF Badylak. (1998). Application and evaluation of the Alamar blue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev Biol Anim 34:239–246.
  • H Mueller, MU Kassack, and M: Wiese. (2004). Comparison of the usefulness of MTT, ATP, and Calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. J Biomol Screen 9:506–515.
  • B Pagé, M Pagé, and C:A Noël. (1993). new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 3:473–476.
  • GR Nakayama, MC Caton, MP Nova, and Z Parandoosh. (1997). Assessment of the Alamar blue assay for cellular growth and viability in vitro. J Immunol Meth 204:205–208.
  • R Hamid, Y Rotshteyn, L Rabadi, R Parikh, and P: Bullock. (2004). Comparsion of Alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 18:703–710.
  • TA Shahan, PD Siegel, WG Sorenson, WG Kuschner, and DM Lewis. (1994). A sensitive new bioassay for tumor necrosis factor. J Immunol Meth 175:181–187.
  • SA Ahmed, RM GogalJr, and JE Walsh. (1994). A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assay. J Immunol Meth 170:211–224.
  • R De Fries, and M Mitsuhashi. (1995). Quantification of mitogen induced human lymphocyte proliferation: Comparison of Alamar blue assay to 3H-thymidine incorporation assay. J Clin Lab Anal. 9:89–95.
  • DL Saltman, PG Cachia, AE Dear, FM Ross, AS Krajewski, C Ludham, and CM Steel. (1988). Characterization of a new non-Hodgkin's lymphoma cell line (NCEB1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)]. Blood 72:2026–2030.
  • C Antcak, D Shum, S Escobar, B Bassit, E Kim, E Venkatraman, N Wu, G Yang, O Ouerfelli, Y-M Li, DA Scheinberg, and H Djaballah. (2007). High-throughput identification of inhibitors of human mitochondrial peptide deformylase. J Biomol Screen 12:521–535.
  • R Macarron, and RP Hertzberg. (2002). Design and implementation of high throughput screening assays. Meth Mol Biol 190:1–29.
  • TE Witzig. (2005). Current treatment approaches for Mantle-cell lymphoma. J Clin Oncol 23:6409–6411.
  • LM Leoni, E Hamel, D Genini, H Shih, CJ Carrera, HB Cottam, and DA: Carson. (2000). Indanocine, a microtubule binding indanone and a selective inducer of apoptosis in multidrug-resistant cancer cells. J Natl Cancer Inst 92:217–224.
  • JH Myklebust, D Josefsen, HK Blomhoff, FO Levy, S Naderi, JC Reed, and EB Smeland. (1999). Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of mcl-1 expression. J Cell Physiol 180:71–80.
  • S Omura, Y Iwai, A Hirano, A Nakagawa, J Awaya, H Tsuchya, Y Takahashi, and R Masuma. (1977). A new alkaloid AM-2282 of Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J Antibiot 30:275–282.
  • EY Moon, and A Lerner. (2003). PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A. Blood 101:4122–4130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.